News

Quince Therapeutics is advancing eDSP for Ataxia-Telangiectasia, leveraging strong prior data in the 6-9 age group and an innovative AIDE platform. Recent insider buying, new analyst coverage with ...
Spinocerebellar Ataxia Type 3 is one of the most common dominantly inherited ataxias globally and is marked by progressive loss of coordination, balance, and motor control. CRD’s therapeutic ...
At that time, the biotech said it had completed a mid-cycle review meeting for troriluzole in the neurodegenerative disease spinocerebellar ataxia, and the FDA had “not conveyed any intention of ...
(RTTNews) - Biohaven Ltd. (BHVN) announced that the Division of Neurology 1 within FDA's Office of Neuroscience informed the company that they have extended the PDUFA date for the troriluzole new ...
Lexeo Therapeutics announced positive interim data for LX2006 in Phase 1/2 studies targeting Friedreich ataxia (FA) cardiomyopathy, indicating surpassing results in frataxin expression and left ...
After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU.
May 15, 2025: We checked for new Throne and Liberty coupon codes. What are the new Throne and Liberty coupon codes? Getting a coupon code can help you along in your MMO journey, and fortunately ...
A deadly militant attack in Pahalgam, Indian-administered Kashmir, has triggered a sharp escalation between India and Pakistan, with both sides exchanging gunfire across the Line of Control and ...
The FDA has pushed back by three months its decision date for Biohaven’s investigational glutamate modulator troriluzole for the treatment of spinocerebellar ataxia, the biotech announced Wednesday ...
Spinocerebellar Ataxia Type 3 is one of the most common dominantly inherited ataxias globally and is marked by progressive loss of coordination, balance, and motor control. CRD’s therapeutic approach ...
Patients typically present with a progressive syndrome including various combinations of cognitive impairment, movement disorders, ataxia and upper motor neuron signs. There are a number of important ...